Home

Spruce Biosciences, Inc. (SPRB)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Spruce Biosciences, Inc. (SPRB)

Go deeper and ask any question about SPRB

Company Performance

Current Price

as of Sep 13, 2024

$0.47

P/E Ratio

N/A

Market Cap

$19.22M

Description

Spruce Biosciences, Inc. is a late-stage biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. It focuses on developing its wholly owned product candidate, Tildacerfont. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.

Metrics

Overview

  • HQSouth San Francisco, CA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerSPRB
  • Price$0.4653+1.66%

Trading Information

  • Market Cap$19.22M
  • Float69.04%
  • Average Daily Volume (1m)224,641
  • Average Daily Volume (3m)429,229
  • EPS-$1.05

Company

  • Revenue$9.57M
  • Rev Growth (1yr)-25.64%
  • Net Income-$9.18M
  • Gross Margin99.25%
  • EBITDA Margin-622.61%
  • EBITDA-$10.02M
  • EV-$44.68M
  • EV/Revenue-4.67
  • P/EN/A
  • P/S2.00
Documents